Skip to main content
Premium Trial:

Request an Annual Quote

Number Crunch: Mar 1, 2001

Premium

Several genomics firms were among more than 100 that were swept off NASDAQ''''s Biotech Index in January. NASDAQ doesn''''t keep companies with low share volume and stock price in the index. Here''''s how the Genome Technology Index-listed companies that were kicked out and those that cling on were performing on January 19, 2001, the Friday before the cut.

Survivors: Affymetrix, Aurora Biosciences, Gene Logic, Incyte Genomics, Lexicon Genetics, Luminex. Goners: Compugen, DeCode Genetics, Informax, Lynx Therapeutics, Rosetta Inpharmatics, Variagenics.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.